Literature DB >> 22816545

Risk stratification for serious arrhythmic events using nonsustained ventricular tachycardia and heart rate turbulence detected by 24-hour holter electrocardiograms in patients with left ventricular dysfunction.

Yosuke Miwa1, Hideaki Yoshino, Kyoko Hoshida, Mutsumi Miyakoshi, Takehiro Tsukada, Satoru Yusu, Takanori Ikeda.   

Abstract

BACKGROUND: Previous studies have described the clinical usefulness of the presence of nonsustained ventricular tachycardia (NSVT) and defined heart rate turbulence (HRT) in stratifying patients at risk. We prospectively assessed whether HRT can facilitate the predictive accuracy of NSVT for identifying patients at risk for serious arrhythmic events in patients with left ventricular (LV) dysfunction.
METHODS: We enrolled 299 consecutive patients with LV dysfunction (ejection fraction ≤ 40%) including ischemic (n = 184) and nonischemic causes (n = 115). The presence of NSVT was assessed on Holter electrocardiograms (ECGs). HRT was simultaneously measured from Holter ECGs, assessing two parameters: turbulence onset (TO) and turbulence slope (TS). HRT was considered positive when both TO and TS were abnormal. The end point was defined as of sudden cardiac death (SCD) and sustained ventricular tachyarrhythmias (VTs).
RESULTS: NSVT was documented in 93 patients (32.7%). For HRT assessment, 17 patients (5.6%) were not utilized. Of 282 patients, 68 (24.1%) were HRT positive. During follow-up of 960 ± 444 days, 14 patients (5.0%) reached the end point. NSVT, HRT, and diabetes were significantly associated with the end point. On multivariate analysis, NSVT had the strongest value for the end point, with an HR of 4.4 (95%CI, 1.4-14.3; P = 0.0138). When NSVT combined with HRT, the predictive accuracy is more increased, with an HR of 8.2 (95%CI, 2.9-23.3; P < 0.0001). The predictive values of the combination were higher than single use of NSVT or HRT.
CONCLUSIONS: HRT can facilitate the predictive accuracy of NSVT for identifying patients at risk for serious arrhythmic events in patients with LV dysfunction. ©2012, Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22816545      PMCID: PMC6932661          DOI: 10.1111/j.1542-474X.2012.00522.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  30 in total

1.  Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndrome-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36) randomized controlled trial.

Authors:  Benjamin M Scirica; Eugene Braunwald; Luiz Belardinelli; Chester M Hedgepeth; Jindrich Spinar; Whedy Wang; Jie Qin; Ewa Karwatowska-Prokopczuk; Freek W A Verheugt; David A Morrow
Journal:  Circulation       Date:  2010-07-19       Impact factor: 29.690

2.  ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death).

Authors:  Douglas P Zipes; A John Camm; Martin Borggrefe; Alfred E Buxton; Bernard Chaitman; Martin Fromer; Gabriel Gregoratos; George Klein; Arthur J Moss; Robert J Myerburg; Silvia G Priori; Miguel A Quinones; Dan M Roden; Michael J Silka; Cynthia Tracy; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Elliott M Antman; Jeffrey L Anderson; Sharon A Hunt; Jonathan L Halperin; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Silvia G Priori; Jean-Jacques Blanc; Andrzej Budaj; A John Camm; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; Juan Luis Tamargo; José Luis Zamorano
Journal:  J Am Coll Cardiol       Date:  2006-09-05       Impact factor: 24.094

3.  Fractal correlation properties of R-R interval dynamics and mortality in patients with depressed left ventricular function after an acute myocardial infarction.

Authors:  H V Huikuri; T H Mäkikallio; C K Peng; A L Goldberger; U Hintze; M Møller
Journal:  Circulation       Date:  2000 Jan 4-11       Impact factor: 29.690

4.  Prevalence, characteristics and significance of ventricular premature complexes and ventricular tachycardia detected by 24-hour continuous electrocardiographic recording in the Cardiac Arrhythmia Suppression Trial. CAST Investigators.

Authors:  P Denes; A M Gillis; Y Pawitan; J M Kammerling; L Wilhelmsen; D M Salerno
Journal:  Am J Cardiol       Date:  1991-10-01       Impact factor: 2.778

5.  Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation.

Authors:  A M Keogh; D W Baron; J B Hickie
Journal:  Am J Cardiol       Date:  1990-04-01       Impact factor: 2.778

6.  Risk stratification after acute myocardial infarction by heart rate turbulence.

Authors:  Petra Barthel; Raphael Schneider; Axel Bauer; Kurt Ulm; Claus Schmitt; Albert Schömig; Georg Schmidt
Journal:  Circulation       Date:  2003-08-25       Impact factor: 29.690

Review 7.  Nonsustained ventricular tachycardia: identification and management of high-risk patients.

Authors:  L A Pires; S K Huang
Journal:  Am Heart J       Date:  1993-07       Impact factor: 4.749

8.  Heart rate turbulence predicts all-cause mortality and sudden death in congestive heart failure patients.

Authors:  Iwona Cygankiewicz; Wojciech Zareba; Rafael Vazquez; Montserrat Vallverdu; Jose R Gonzalez-Juanatey; Mariano Valdes; Jesus Almendral; Juan Cinca; Pere Caminal; Antoni Bayes de Luna
Journal:  Heart Rhythm       Date:  2008-05-02       Impact factor: 6.343

9.  Predictive value of microvolt T-wave alternans in patients with left ventricular dysfunction.

Authors:  Daniel J Cantillon; Kenneth M Stein; Steven M Markowitz; Suneet Mittal; Bindi K Shah; Daniel P Morin; Eran S Zacks; Matthew Janik; Shaun Ageno; Andreas C Mauer; Bruce B Lerman; Sei Iwai
Journal:  J Am Coll Cardiol       Date:  2007-06-21       Impact factor: 24.094

10.  Improved Stratification of Autonomic Regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISAR-Risk).

Authors:  Axel Bauer; Petra Barthel; Raphael Schneider; Kurt Ulm; Alexander Müller; Anke Joeinig; Raphael Stich; Antti Kiviniemi; Katerina Hnatkova; Heikki Huikuri; Albert Schömig; Marek Malik; Georg Schmidt
Journal:  Eur Heart J       Date:  2008-12-23       Impact factor: 29.983

View more
  4 in total

Review 1.  Non-invasive evaluation of arrhythmic risk in dilated cardiomyopathy: From imaging to electrocardiographic measures.

Authors:  Massimo Iacoviello; Francesco Monitillo
Journal:  World J Cardiol       Date:  2014-07-26

2.  SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death.

Authors:  Wan-Tai M Au-Yeung; Per G Reinhall; Jeanne E Poole; Jill Anderson; George Johnson; Ross D Fletcher; Hans J Moore; Daniel B Mark; Kerry L Lee; Gust H Bardy
Journal:  Heart Rhythm       Date:  2015-06-19       Impact factor: 6.343

3.  Prognostic significance of heart rate turbulence parameters in patients with chronic heart failure.

Authors:  De-Chun Yin; Zhao-Jun Wang; Shuai Guo; Hong-Yu Xie; Lin Sun; Wei Feng; Wei Qiu; Xiu-Fen Qu
Journal:  BMC Cardiovasc Disord       Date:  2014-04-13       Impact factor: 2.298

4.  Combined evaluation of ambulatory-based late potentials and nonsustained ventricular tachycardia to predict arrhythmic events in patients with previous myocardial infarction: A Japanese noninvasive electrocardiographic risk stratification of sudden cardiac death (JANIES) substudy.

Authors:  Kenichi Hashimoto; Mari Amino; Koichiro Yoshioka; Yuji Kasamaki; Toshio Kinoshita; Takanori Ikeda
Journal:  Ann Noninvasive Electrocardiol       Date:  2020-09-24       Impact factor: 1.468

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.